Re-Vana Therapeutics



Re-Vana Therapeutics is an ocular pharmaceutical​ and drug delivery company focused on the development and commercialisation of revolutionary long-acting biodegradable drug delivery platforms to treat chronic eye diseases such as age-related macular degeneration, diabetic retinopathy, glaucoma and ocular infections.


Add photos to showcase Re-Vana Therapeutics’s culture


Add Re-Vana Therapeutics’s values

Insider experiences

Share your experience of working at Re-Vana Therapeutics

Michael O’rourke
CEO & Director
Thakur Raghu Raj Singh
Co-Founder, CTO & Director
Clive Wilson
Chief Scientific Officer & Head of Advisory Board
Mike Nash
Chief Commercial Officer
Rahul Sonawane
Research Fellow
Yujing Wang
Research Fellow
David Waite
Research Fellow

Add your teams to show how people work together at Re-Vana Therapeutics

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.